Home » Stocks » HSIC

Henry Schein, Inc. (HSIC)

Stock Price: $80.22 USD 0.78 (0.98%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
Market Cap 11.11B
Revenue (ttm) 10.62B
Net Income (ttm) 439.53M
Shares Out 142.30M
EPS (ttm) 3.07
PE Ratio 26.14
Forward PE 20.70
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $80.22
Previous Close $79.44
Change ($) 0.78
Change (%) 0.98%
Day's Open 79.78
Day's Range 79.40 - 80.32
Day's Volume 435,745
52-Week Range 56.31 - 83.45

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Henry Schein's (HSIC) PPE sales from medical business are likely to have maintained momentum in Q2. Also, global recovery trends of its dental business are expected to reflect on Q2 results.

1 day ago - Zacks Investment Research

HSIC vs. COO: Which Stock Is the Better Value Option?

Other stocks mentioned: COO
1 week ago - Zacks Investment Research

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will r...

1 week ago - Business Wire

Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

1 week ago - Zacks Investment Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

2 weeks ago - Zacks Investment Research

Dental stocks like Henry Schein (HSIC), Align Technology (ALGN), Straumann Holding (SAUHF) and DENTSPLY SIRONA (XRAY) are expected to continue their run over the next few months.

Other stocks mentioned: ALGN, PDCO, XRAY
3 weeks ago - Zacks Investment Research

Stocks like Henry Schein (HSIC), BellRing Brands (BRBR), Harrow Health (HROW) and West Pharmaceuticals Services (WST) are solid low-beta picks with strong fundamentals.

Other stocks mentioned: BRBR, HROW, WST
3 weeks ago - Zacks Investment Research

HSIC vs. COO: Which Stock Is the Better Value Option?

Other stocks mentioned: COO
3 weeks ago - Zacks Investment Research

Top Ranked Growth Stocks to Buy for July 1st

Other stocks mentioned: HCCI, VALE, X
4 weeks ago - Zacks Investment Research

Grab these three top stocks, EYE, WST and HSIC, which continue to show promise amid the pandemic and can turn out to be wise investment choices for 2021.

Other stocks mentioned: BDX, EYE, WST
4 weeks ago - Zacks Investment Research

Top Ranked Growth Stocks to Buy for June 29th

Other stocks mentioned: HCCI, TGT, X
1 month ago - Zacks Investment Research

Here are four MedTech stocks, HSIC, BRBR, MRVI and EYE, with favorable Zacks Rank and stellar growth parameters.

Other stocks mentioned: ALGN, BRBR, EYE, MRVI, ZBH
1 month ago - Zacks Investment Research

Top Ranked Growth Stocks to Buy for June 24th

Other stocks mentioned: FB, M, TNC
1 month ago - Zacks Investment Research

Top Ranked Growth Stocks to Buy for June 23rd

Other stocks mentioned: AN, HCCI, TGT
1 month ago - Zacks Investment Research

Investors continue to be optimistic about Henry Schein (HSIC) on its extensive global foothold and bullish 2021 earnings guidance.

1 month ago - Zacks Investment Research

Fundamentally-sound stocks like Henry Schein (HSIC), UnitedHealth Group (UNH) and Phibro Animal Health (PAHC) are trading at a discount and make great picks for the long term.

Other stocks mentioned: PAHC, UNH
1 month ago - Zacks Investment Research

MELVILLE, N.Y.--(BUSINESS WIRE)-- #HENRYSCHEIN--Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in the Southeast that the Henry Schein Customer Assistance Hotline is open for dentists and physic...

1 month ago - Business Wire

New Strong Buy Stocks for June 18th

Other stocks mentioned: ATUS, FISI, GLOP, LCII
1 month ago - Zacks Investment Research

HSIC vs. COO: Which Stock Is the Better Value Option?

Other stocks mentioned: COO
1 month ago - Zacks Investment Research

Top Ranked Growth Stocks to Buy for June 18th

Other stocks mentioned: AN, GOOGL, LL
1 month ago - Zacks Investment Research

Here we look at three stocks, VEEV, HSIC and BDX, that investors can keep a watch on the back of their robust cybersecurity measures.

Other stocks mentioned: BAX, BDX, VEEV
1 month ago - Zacks Investment Research

Top Ranked Growth Stocks to Buy for June 15th

Other stocks mentioned: FB, HCCI, SNA
1 month ago - Zacks Investment Research

Henry Schein's (HSIC) acquisition of majority stake in eAssist will enable it to offer best quality solutions to help dental practices operate efficiently and profitably.

1 month ago - Zacks Investment Research

Here are some MedTech stocks with favorable PEG ratio, which are expected to provide gains in 2021.

Other stocks mentioned: DVA, ELAN, EYE, MDT, PAHC, XENT
1 month ago - Zacks Investment Research

These five MedTech stocks, EYE, MRVI, SONVY, SARTF and HSIC, all with a favorable Zacks Rank and growth parameters are expected to put up a robust performance in 2021.

Other stocks mentioned: ALGN, EYE, MRVI, SARTF, ZBH
1 month ago - Zacks Investment Research

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. acquires majority interest in eAssist Dental Solutions.

1 month ago - Business Wire

Top Ranked Growth Stocks to Buy for June 8th

Other stocks mentioned: GOOGL, LL, PVH, GOOG
1 month ago - Zacks Investment Research

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?

1 month ago - Zacks Investment Research

HSIC vs. SAUHF: Which Stock Is the Better Value Option?

1 month ago - Zacks Investment Research

Henry Schein (HSIC) to extend effective inventory management and extensive logistical support for PPE and COVID related products within the spectrum of U.S. health care.

1 month ago - Zacks Investment Research

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. awarded Strategic National Stockpile contract for PPE storage and distribution.

2 months ago - Business Wire

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein One acquires majority interest in Jarvis Analytics.

2 months ago - Business Wire

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein Donates More than 2.5 Million Personal Protective Equipment and Infection Control Items to Health Care Workers in Brazil and India

2 months ago - Business Wire

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein to present at four virtual investor conferences in June 2021.

2 months ago - Business Wire

Investors are optimistic about Henry Schein (HSIC) on solid first-quarter performance and strategic deals.

2 months ago - Zacks Investment Research

HSIC vs. CNMD: Which Stock Is the Better Value Option?

Other stocks mentioned: CNMD
2 months ago - Zacks Investment Research

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. elects Reed V. Tuckson, M.D., FACP to the Company's Board of Directors.

2 months ago - Business Wire

The Benzinga Global Small Cap Conference on May 13 featured presentations from publicly-traded companies and educational segments for investors. Among the featured segments was one from Chris Capre on h...

Other stocks mentioned: ANTM, CI, CVS, IQV, MDT, UNH
2 months ago - Benzinga

Henry Schein's (HSIC) latest software module is expected to provide better patient care and improved patient experience.

2 months ago - Zacks Investment Research

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein announces $400 million increase to share repurchase plan.

2 months ago - Business Wire

As of late, it has definitely been a great time to be an investor in Henry Schein, Inc. (HSIC).

2 months ago - Zacks Investment Research

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today a series of ef...

2 months ago - Business Wire

AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One Announces Enhancement of its AxiUm Dental Software by Integrating Dental and Medical Patient Records

2 months ago - Business Wire

Henry Schein (HSIC) is optimistic about maintaining robust sales of PPE and COVID-19-related products.

2 months ago - Zacks Investment Research

Henry Schein (HSIC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

2 months ago - Zacks Investment Research

Henry Schein (HSIC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ...

2 months ago - Zacks Investment Research

Henry Schein Inc (NASDAQ: HSIC) raised its 2021 guidance after reporting first-quarter earnings, which topped the consensus. It posted an adjusted EPS of $1.24 ahead of the consensus of $0.85.

2 months ago - Benzinga

Henry Schein (HSIC) sees robust segmental performance in Q1 boosted by strong rebound in sales, and solid demand for PPE and COVID-19-related products.

2 months ago - Zacks Investment Research

Henry Schein (HSIC) delivered earnings and revenue surprises of 49.40% and 3.55%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Henry Schein (NASDAQ:HSIC) decreased 3.0% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 31.91% over the past year to $1.24, which ...

2 months ago - Benzinga

About HSIC

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives... [Read more...]

Industry
Medical Distribution
IPO Date
Nov 3, 1995
CEO
Stanley Bergman
Employees
20,000
Stock Exchange
NASDAQ
Ticker Symbol
HSIC
Full Company Profile

Financial Performance

In 2020, Henry Schein's revenue was $10.12 billion, an increase of 1.34% compared to the previous year's $9.99 billion. Earnings were $403.79 million, a decrease of -41.88%.

Financial Statements

Analyst Forecasts

According to 17 analysts, the average rating for Henry Schein stock is "Buy." The 12-month stock price forecast is 83.31, which is an increase of 3.85% from the latest price.

Price Target
$83.31
(3.85% upside)
Analyst Consensus: Buy